Results 71 to 80 of about 341,782 (119)

Comparing the clinical accuracy of urine exfoliated cell examination and fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. [PDF]

BMC Urol
Wang C, Liu Y, Zhang C, Wang C, Wu J, Xiao F, Jin J.   +6 more
europepmc   +1 more source

Hierarchical friction memory leads to subdiffusive configurational dynamics of fast-folding proteins. [PDF]

Proc Natl Acad Sci U S A
Klimek A, Dalton BA, Tepper L, Netz RR.
europepmc   +1 more source

Copy-Number Aberrations in Circulating Tumor DNA Enable Diagnosis and Risk Stratification of Pediatric Neuroblastic Tumors. [PDF]

Cancer Res Commun
Tao T, Cai J, Tang Y, Lu D, Zhang L, Peng J, Wang Y, Gu W, Zhang S, Wang J.   +9 more
europepmc   +1 more source

P225 | IMPROVED OUTCOME WITH AVAPRITINIB VS MIDOSTAURIN IN SYSTEMIC MASYOCYTOSIS: A SINGLE-CENTER EXPERIENCE

Haematologica
BACKGROUND: Adverse systemic mastocytosis (AdvSM) includes the most aggressive SM subtypes; cKITD816V is recognized as a driver mutation in ~95% of cases. Therefore, Tyrosine Kinase Inhibitors (TKIs) represent the standard of care. Avapritinib is a new,
M. Fazio, S. Stella, T. Chiara, B. Esposito, A. Duminuco, F. Di Raimondo, A. Romano   +6 more
doaj  

Do Magnesium Ions Have Similar Effects as Calcium Ions on Resting Membrane Potential? [PDF]

Membranes (Basel)
Hana A, Kim Y, Bidros J, Neglia K, Cooper RL.   +4 more
europepmc   +1 more source

Commentary on "The effects of self-compassion in adolescents and young adults with type 1 diabetes: a pilot randomized controlled trial&quot. [PDF]

Ann Pediatr Endocrinol Metab
Fatima M, Ahmad H, Munir I.
europepmc   +1 more source

Early-life obesity as a risk factor for central precocious puberty - A commentary on "Incidence of central precocious puberty and the role of body mass index in Korea&quot. [PDF]

Ann Pediatr Endocrinol Metab
Lee HS.
europepmc   +1 more source

P040 | REAL-WORLD EXPERIENCE WITH BISPECIFIC ANTIBODY EPCORITAMAB IN RELAPSED/REFRACTORY DLBCL: A MULTICENTRIC RETROSPECTIVE ANALYSIS

Haematologica
Background: Epcoritamab is approved for relapsed/refractory DLBCL from the third line onward. Pivotal trial results showed high efficacy and good safety. However, real-world data are limited, with some studies showing less favorable outcomes.
M. Porrazzo, V. Tarantino, G. Catalano, R. Scalone, G.A. Milone, G. Amato, M. Rossi, L. Scalise, A. Greco, V. Di Martina, M. Martino, L. Castagna, C. Patti   +12 more
doaj  

Metagenomic next-generation sequencing for the diagnosis and evaluation of pediatric pleural effusion: a case series. [PDF]

BMC Pulm Med
Xu Z, Gao L, Chen Z, Tang L, Wang Y.
europepmc   +1 more source

Governing the AI-biotech convergence : The rapid progress in and the dual-use nature of biotechnology and AI requires adaptive and resilient regulatory frameworks to address potential risks. [PDF]

EMBO Rep
Trump BD, Cummings CL, Ellinport B, Galaitsi S, Janisko T, Pinigina E, Herzig H, Groff-Vindman CS, Schmidt M, Epstein G, Mampuys R, Haggenmiller C, Novossiolova T, Tubbs T, Lambert JH, Titus A, Linkov I.   +16 more
europepmc   +1 more source